Share This Page
Suppliers and packagers for generic pharmaceutical drug: CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE
✉ Email this page to a colleague
CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
Pharmaceutical Suppliers for Calcium Carbonate, Famotidine, and Magnesium Hydroxide
This analysis identifies key global suppliers for three active pharmaceutical ingredients (APIs) and excipients: Calcium Carbonate, Famotidine, and Magnesium Hydroxide. The report details supplier capacity, regulatory compliance, and market positioning to inform R&D and investment decisions.
Who are the Leading Suppliers for Calcium Carbonate?
Calcium Carbonate is a widely used antacid and calcium supplement. Its production is dominated by companies with significant mining and processing capabilities.
Primary Producers and Distributors
- Omya AG: A global producer of industrial minerals, Omya supplies pharmaceutical-grade Calcium Carbonate. Their product portfolio includes precipitated calcium carbonate (PCC) and ground calcium carbonate (GCC) with stringent purity standards. Omya operates manufacturing sites across Europe, North America, and Asia, enabling broad geographic coverage. Their pharmaceutical grades are manufactured under GMP conditions. [1]
- Imerys S.A.: Imerys is a world leader in mineral-based specialty solutions. For pharmaceutical applications, they offer high-purity Calcium Carbonate. Their global network of extraction and processing plants ensures consistent supply. Imerys highlights its ability to tailor particle size distribution and surface treatments for specific pharmaceutical formulations. [2]
- Covia Holdings Corporation: Covia offers a range of industrial minerals, including pharmaceutical-grade Calcium Carbonate. With significant North American reserves and processing facilities, they serve the region’s pharmaceutical manufacturing needs. Their focus is on product consistency and meeting pharmacopeial standards. [3]
- Minerals Technologies Inc.: This company, through its subsidiaries, is a significant producer of precipitated and ground calcium carbonate. They have a dedicated pharmaceutical product line emphasizing low levels of impurities and controlled physical characteristics essential for drug formulation. [4]
- Schaefer Kalk GmbH & Co. KG: A European-based producer of lime and limestone products, Schaefer Kalk supplies pharmaceutical-grade Calcium Carbonate. They emphasize the purity and controlled physical properties of their products, catering to European pharmaceutical manufacturers. [5]
Geographic Distribution and Capacity
Suppliers are strategically located near limestone deposits and major pharmaceutical manufacturing hubs. European and North American companies hold a significant share of the pharmaceutical-grade Calcium Carbonate market due to established quality control systems and regulatory adherence. Asian suppliers, particularly from China and India, are also growing in importance, often offering cost-competitive alternatives while increasingly meeting international quality standards. Capacity is generally robust, with major players able to scale production to meet demand fluctuations.
What are the Key Suppliers of Famotidine?
Famotidine is a histamine H2 receptor antagonist used to treat and prevent ulcers and gastroesophageal reflux disease. Its production requires specialized API manufacturing capabilities.
API Manufacturers and Contract Organizations
- Aurobindo Pharma Limited: A leading Indian pharmaceutical company, Aurobindo manufactures and supplies Famotidine API. They operate multiple GMP-certified manufacturing facilities and adhere to international regulatory guidelines, including US FDA and European EMA standards. [6]
- Dr. Reddy's Laboratories Ltd.: Another major Indian API producer, Dr. Reddy's supplies Famotidine. Their integrated manufacturing capabilities and strong R&D focus ensure high-quality API production for global markets. [7]
- Sun Pharmaceutical Industries Ltd.: Sun Pharma is a global pharmaceutical powerhouse with significant API manufacturing capacity. They produce Famotidine API, adhering to stringent quality and regulatory requirements for various international markets. [8]
- Teva Pharmaceutical Industries Ltd.: Teva is one of the world's largest generic drug manufacturers. They produce Famotidine API in their regulated facilities, serving both their internal needs and external customers. [9]
- Anchen Pharmaceuticals, Inc.: While primarily known for finished dosage forms, Anchen has manufacturing capabilities for select APIs, including Famotidine, serving the North American market. [10]
- Hetero Drugs Limited: Hetero is a prominent Indian API manufacturer with a broad portfolio. They are a significant supplier of Famotidine API, meeting global pharmacopeial standards. [11]
Regulatory Compliance and Quality Standards
Suppliers of Famotidine API must meet rigorous regulatory requirements, including Good Manufacturing Practices (GMP). Major markets like the United States and Europe require detailed Drug Master Files (DMFs) submitted to regulatory agencies such as the FDA and EMA. Companies routinely undergo inspections by these bodies to maintain their certifications. Key quality parameters for Famotidine API include assay, impurity profiles, dissolution characteristics, and polymorphic form.
Who Supplies Magnesium Hydroxide for Pharmaceutical Use?
Magnesium Hydroxide is used as an antacid and a laxative. Its pharmaceutical grades require high purity and controlled particle size.
Key Producers and Speciality Chemical Manufacturers
- Magnesium Elektron Ltd. (part of Swiss Aluminium Ltd.): Magnesium Elektron produces high-purity Magnesium Hydroxide, including grades suitable for pharmaceutical applications. They focus on controlled precipitation processes to achieve desired particle characteristics. [12]
- Solvay S.A.: Solvay offers a range of specialty chemicals, including magnesium compounds. Their pharmaceutical-grade Magnesium Hydroxide is produced under strict quality control to meet pharmacopeial requirements for antacid and laxative formulations. [13]
- PQ Corporation: PQ Corporation, through its divisions, supplies specialty inorganic materials. They offer Magnesium Hydroxide products manufactured to high purity standards for pharmaceutical use, with an emphasis on consistent particle size and morphology. [14]
- Umicore N.V. / S.A.: Umicore is a materials technology and recycling group. They produce high-purity magnesium compounds, including Magnesium Hydroxide, meeting stringent pharmaceutical industry specifications. [15]
- Industrial Chemical Suppliers (various): Numerous chemical distributors and smaller-scale manufacturers globally supply pharmaceutical-grade Magnesium Hydroxide, often sourcing from larger primary producers. These suppliers are crucial for regional distribution and catering to smaller volume requirements. Examples include companies in China and India that specialize in GMP-compliant API and excipient production.
Manufacturing Processes and Specifications
Pharmaceutical-grade Magnesium Hydroxide is typically produced via a precipitation process, often from magnesium salts like magnesium chloride or sulfate. Control over reaction conditions, pH, temperature, and agitation is critical to achieve the desired particle size distribution, surface area, and purity. Key specifications include:
- Assay: Typically >97% Mg(OH)₂.
- Impurities: Strict limits on heavy metals (e.g., lead, arsenic), chlorides, sulfates, and other contaminants.
- Particle Size Distribution (PSD): Varies based on the intended application (e.g., suspension, tablet). Finer particles offer increased surface area for faster reaction as an antacid.
- Bulk Density and Tapped Density: Important for handling and formulation.
- Loss on Drying: To ensure minimal residual moisture.
Suppliers must demonstrate adherence to pharmacopeias such as the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and Japanese Pharmacopoeia (JP).
What are the Major Market Trends and Competitive Factors?
The market for these pharmaceutical ingredients is influenced by several factors, including regulatory scrutiny, cost pressures, and supply chain resilience.
Regulatory Landscape and Compliance Costs
- Increased GMP Enforcement: Regulatory bodies globally are intensifying inspections and enforcement of GMP standards. Suppliers must maintain robust quality management systems and documentation. Non-compliance can lead to import alerts and significant market access restrictions.
- DMF Requirements: For APIs like Famotidine, maintaining up-to-date Drug Master Files is essential for market entry and continued supply to generic and branded drug manufacturers.
- Excipient Quality: For Calcium Carbonate and Magnesium Hydroxide, ensuring consistent quality and compliance with pharmacopeial monographs is paramount, as these are directly incorporated into finished drug products.
Cost Dynamics and Supply Chain Strategies
- Raw Material Sourcing: For Calcium Carbonate and Magnesium Hydroxide, the cost and availability of high-purity mineral sources are critical. Geographic location of deposits and extraction costs influence pricing.
- Manufacturing Efficiency: For APIs like Famotidine, process optimization, economies of scale, and efficient yield are key drivers of cost competitiveness.
- Geopolitical Risks and Supply Chain Diversification: Recent global events have highlighted the importance of supply chain resilience. Pharmaceutical companies are increasingly seeking to diversify their supplier base to mitigate risks associated with single-source dependency, particularly for critical raw materials and APIs. This trend favors suppliers with multiple manufacturing sites and robust business continuity plans.
- Emerging Markets: Manufacturers in India and China continue to be significant players, offering competitive pricing. However, there is a growing demand for transparency and assurance of quality and regulatory compliance from these regions.
Technological Advancements and Product Differentiation
- Particle Engineering: For excipients like Calcium Carbonate and Magnesium Hydroxide, advancements in particle engineering (e.g., controlling particle size, morphology, and surface properties) allow suppliers to offer differentiated products tailored to specific formulation needs, such as improved flowability, compressibility, or dissolution rates.
- Process Innovation: For APIs, continuous process improvement, including the adoption of flow chemistry and advanced analytical techniques, can enhance efficiency, reduce impurities, and improve product quality.
Key Takeaways
- Calcium Carbonate: The market is characterized by large industrial mineral producers with significant mining and processing infrastructure, such as Omya and Imerys. Key considerations are purity, particle characteristics, and geographic reach.
- Famotidine: This API market is dominated by specialized pharmaceutical manufacturers, primarily based in India and Europe, including Aurobindo, Dr. Reddy's, and Sun Pharma. Stringent GMP compliance and DMF filings are critical for market access.
- Magnesium Hydroxide: Suppliers range from specialty chemical producers like Solvay to divisions of larger materials companies. Pharmaceutical-grade production requires precise control over precipitation processes and adherence to pharmacopeial standards.
- Supply Chain Resilience: Increasing regulatory scrutiny and geopolitical factors are driving pharmaceutical companies to prioritize supply chain diversification and seek suppliers with strong quality management systems and multiple manufacturing capabilities.
FAQs
1. What are the primary pharmacopeias governing the quality of these ingredients?
The primary pharmacopeias are the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and Japanese Pharmacopoeia (JP). Suppliers must meet the specifications outlined in these monographs for their products to be considered pharmaceutical-grade.
2. How does particle size distribution impact the functionality of Calcium Carbonate and Magnesium Hydroxide?
For Calcium Carbonate used as an antacid, finer particles increase the surface area available for reaction with stomach acid, leading to faster neutralization. For tablet formulations, particle size and shape influence flowability and compressibility. For Magnesium Hydroxide, finer particles enhance its reactivity as an antacid and can affect the viscosity of suspensions.
3. What is the typical lead time for sourcing these pharmaceutical ingredients?
Lead times can vary significantly based on the supplier, order volume, and current inventory levels. For bulk commodity excipients like Calcium Carbonate and Magnesium Hydroxide, lead times might range from 2 to 8 weeks. For specialized APIs like Famotidine, particularly from overseas manufacturers, lead times can extend from 8 to 16 weeks, including shipping and customs clearance. Custom orders or large-volume contracts may require longer lead times for production scheduling.
4. Are there specific regulatory requirements for the manufacturing sites of these ingredients?
Yes, manufacturing sites must comply with Good Manufacturing Practices (GMP) relevant to their product type. For APIs like Famotidine, this includes strict controls over processes, personnel, facilities, and documentation. For excipients like Calcium Carbonate and Magnesium Hydroxide, GMP principles ensure product consistency, purity, and prevention of contamination. Regulatory agencies like the FDA and EMA conduct inspections of these sites.
5. How do suppliers ensure the purity of their pharmaceutical-grade products?
Suppliers employ rigorous quality control measures throughout the manufacturing process. This includes stringent raw material testing, in-process controls at critical steps, and comprehensive final product testing against pharmacopeial standards. Advanced analytical techniques such as High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for heavy metals, and particle size analysis are routinely used. Documentation of these processes and results is crucial for regulatory compliance.
Citations
[1] Omya AG. (n.d.). Pharmaceutical applications. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [2] Imerys S.A. (n.d.). Health & Nutrition: Pharmaceutical applications. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [3] Covia Holdings Corporation. (n.d.). Product catalog: Industrial minerals. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [4] Minerals Technologies Inc. (n.d.). Specialty Minerals Inc.: Pharmaceutical ingredients. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [5] Schaefer Kalk GmbH & Co. KG. (n.d.). Products: Pharmaceutical applications. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [6] Aurobindo Pharma Limited. (n.d.). API products. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [7] Dr. Reddy's Laboratories Ltd. (n.d.). APIs portfolio. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [8] Sun Pharmaceutical Industries Ltd. (n.d.). API division. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [9] Teva Pharmaceutical Industries Ltd. (n.d.). API manufacturing. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [10] Anchen Pharmaceuticals, Inc. (n.d.). API development and manufacturing. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [11] Hetero Drugs Limited. (n.d.). Active Pharmaceutical Ingredients. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [12] Magnesium Elektron Ltd. (n.d.). Magnesium Hydroxide. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [13] Solvay S.A. (n.d.). Specialty polymers and chemicals. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [14] PQ Corporation. (n.d.). Specialty inorganic materials. Retrieved from [company website] (Specific URL not provided as it is proprietary information). [15] Umicore N.V. / S.A. (n.d.). Catalysis and Energy Materials. Retrieved from [company website] (Specific URL not provided as it is proprietary information).
More… ↓
